Abbott Laboratories · Other Income/Expenses (Net)

Latest reported-$421.00Mperiod endingJun 30, 2026

ABT Other Income/Expenses (Net) (-$42.60M → -$421.00M)

Annual Other Income/Expenses (Net)

High-resolution chart · PNG

ABT other income/expenses (net) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period ending	Other Income/Expenses (Net) (USD)
Dec 31, 2025	418,000,000
Dec 31, 2024	188,000,000
Dec 31, 2023	229,000,000
Dec 31, 2022	-56,000,000
Dec 31, 2021	-989,000,000
Dec 31, 2020	-323,000,000
Dec 31, 2019	-514,000,000
Dec 31, 2018	-971,000,000
Dec 31, 2017	259,000,000
Dec 31, 2016	-1,836,000,000
Dec 31, 2015	234,000,000
Dec 31, 2014	-398,000,000
Dec 31, 2013	-105,000,000
Dec 31, 2012	-1,702,000,000
Dec 31, 2011	-1,642,806,000
Dec 31, 2010	-1,337,947,000
Dec 31, 2009	623,033,000
Dec 31, 2008	-232,809,000
Dec 31, 2007	-475,897,000
Dec 31, 2006	-2,059,849,000
Dec 31, 2005	-29,479,000
Dec 31, 2004	-51,726,000
Dec 31, 2003	411,885,000
Dec 31, 2002	143,272,000
Dec 31, 2001	-10,884,000
Dec 31, 2000	415,832,000
Dec 31, 1999	247,525,000
Dec 31, 1998	123,977,000
Dec 31, 1997	84,174,000
Dec 31, 1996	52,439,000
Dec 31, 1995	12,415,000
Dec 31, 1994	22,483,000
Dec 31, 1993	19,264,000
Dec 31, 1992	212,800,000
Dec 31, 1991	-12,800,000
Dec 31, 1990	-55,300,000
Dec 31, 1989	-27,000,000
Dec 31, 1988	-46,600,000
Dec 31, 1987	-68,500,000
Dec 31, 1986	-59,900,000
Dec 31, 1985	-42,600,000